Skip to main content

and
  1. Article

    Open Access

    Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody

    Malaria transmission-blocking vaccines (TBVs) aim to induce antibodies that block Plasmodium parasite development in the mosquito midgut, thus preventing mosquitoes from becoming infectious. While the Pro-domain ...

    Maartje R. Inklaar, Roos M. de Jong, Ezra T. Bekkering, Hikaru Nagaoka in npj Vaccines (2023)

  2. Article

    Open Access

    Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies

    An effective malaria vaccine remains a global health priority and vaccine immunogens which prevent transmission of the parasite will have important roles in multi-component vaccines. One of the most promising ...

    Kuang-Ting Ko, Frank Lennartz, David Mekhaiel, Bora Guloglu in Nature Communications (2022)

  3. Article

    Open Access

    Structure and function of a family of tick-derived complement inhibitors targeting properdin

    Activation of the serum-resident complement system begins a cascade that leads to activation of membrane-resident complement receptors on immune cells, thus coordinating serum and cellular immune responses. Wh...

    Katharina Braunger, Jiyoon Ahn, Matthijs M. Jore, Steven Johnson in Nature Communications (2022)

  4. Article

    Open Access

    Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine

    The Plasmodium falciparum Pfs230 and Pfs48/45 proteins are leading candidates for a malaria transmission-blocking vaccine (TBV). Previously, we showed that a Pfs230–Pfs48/45 fusion protein elicits higher levels o...

    Susheel K. Singh, Jordan Plieskatt, Bishwanath K. Chourasia, Vandana Singh in npj Vaccines (2021)

  5. Article

    Open Access

    Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes

    Malaria parasite transmission to mosquitoes relies on the uptake of sexual stage parasites during a blood meal and subsequent formation of oocysts on the mosquito midgut wall. Transmission-blocking vaccines (T...

    Roos M. de Jong, Lisette Meerstein-Kessel, Dari F. Da, Sandrine Nsango in npj Vaccines (2021)

  6. Article

    Open Access

    Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45

    Interventions that can block the transmission of malaria-causing Plasmodium falciparum (Pf) between the human host and Anopheles vector have the potential to reduce the incidence of malaria. Pfs48/45 is a gametoc...

    Prasun Kundu, Anthony Semesi, Matthijs M. Jore, Merribeth J. Morin in Nature Communications (2018)

  7. Article

    Open Access

    Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody

    The quest to develop an effective malaria vaccine remains a major priority in the fight against global infectious disease. An approach with great potential is a transmission-blocking vaccine which induces anti...

    Frank Lennartz, Florian Brod, Rebecca Dabbs, Kazutoyo Miura in Nature Communications (2018)

  8. Article

    Open Access

    Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity

    The original version of this Article contained errors in Fig. 3. In panel a, bars from a chart depicting the percentage of antibody-positive individuals in non-infectious and infectious groups were inadvertent...

    Will J. R. Stone, Joseph J. Campo, André Lin Ouédraogo in Nature Communications (2018)

  9. Article

    Open Access

    Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity

    Infection with Plasmodium can elicit antibodies that inhibit parasite survival in the mosquito, when they are ingested in an infectious blood meal. Here, we determine the transmission-reducing activity (TRA) of n...

    Will J. R. Stone, Joseph J. Campo, André Lin Ouédraogo in Nature Communications (2018)

  10. No Access

    Article

    Structural basis for therapeutic inhibition of complement C5

    Structural and functional analyses of a new family of tick-derived C5 inhibitors in complex with inhibitor OmCI and therapeutic antibody eculizumab reveal diverse mechanisms for inhibition and provide insight ...

    Matthijs M Jore, Steven Johnson, Devon Sheppard in Nature Structural & Molecular Biology (2016)

  11. No Access

    Article

    DNA-guided DNA interference by a prokaryotic Argonaute

    Here, Argonaute from the prokaryote Thermus thermophilus is shown to use small DNA guides to interfere directly with invading foreign DNA, rather than being involved in RNA-guided RNA interference, as observed in...

    Daan C. Swarts, Matthijs M. Jore, Edze R. Westra, Yifan Zhu, Jorijn H. Janssen in Nature (2014)

  12. No Access

    Article

    Structures of the RNA-guided surveillance complex from a bacterial immune system

    Bacterial cells use CRISPRs (clustered regularly interspaced short palindromic repeats) to defend against invading phages. The central catalytic component in this process is Cascade, a 12-subunit complex consi...

    Blake Wiedenheft, Gabriel C. Lander, Kaihong Zhou, Matthijs M. Jore in Nature (2011)

  13. No Access

    Article

    Structural basis for CRISPR RNA-guided DNA recognition by Cascade

    The CRISPR system is a prokaryotic immune system that depends on the Cascade protein complex and small guide RNAs (crRNAs). The Cascade complex, loaded with crRNA, is now characterized, the overall architectur...

    Matthijs M Jore, Magnus Lundgren, Esther van Duijn in Nature Structural & Molecular Biology (2011)